Postal Service Seeks Approval for Yet More Business Shipping Deals
Published Date: 5/22/2025
Notice
Summary
The Postal Service has asked for approval of new deals that offer special shipping options to businesses. These changes could mean new ways to send mail faster or cheaper, affecting companies that use postal services. If you want to share your thoughts, you have until May 27, 2025, to comment online—no cost to you!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2025-10758, System for Regulating Rates and Classes for Market Dominant Products
Starting in 2025, the Postal Service will only change rates for Market Dominant products once a year until 2030, making prices more predictable and easier to manage. They’ll also fix discounts to better match actual cost savings, stopping unfair price cuts. These changes affect businesses and customers who use postal services and aim to save money and simplify how rates are set.
2025-03042, Market Dominant Postal Products
Starting March 28, 2025, the Postal Regulatory Commission is updating rules about discounts and promotions for popular mail services like First-Class and Marketing Mail. These changes affect mailers who use these services by clarifying how discounts count toward price limits, helping the Postal Service manage rates better. If you send mail regularly, these updates could impact your costs and the timing of discounts.
2026-21620, New Postal Products
The Postal Regulatory Commission is reviewing new deals the Postal Service wants to add or change for competitive mail products. If you use these services, you might see new options or updates soon. Public comments are open until October 27, 2026, so now’s the time to speak up if you have thoughts!
2026-21501, New Postal Products
The Postal Regulatory Commission is reviewing new deals the Postal Service wants to offer for competitive mail services. If you use or work with these services, you can share your thoughts by October 26, 2026. These changes might affect pricing or options, so keep an eye out if you rely on postal products for business or personal use.
2026-21421, New Postal Products
The Postal Service has asked for approval to add or change special deals for competitive mail services. This affects businesses and customers who use these services, with possible new options coming soon. The Postal Regulatory Commission is reviewing the requests and inviting public comments before making decisions.
2026-21068, New Postal Products
The Postal Regulatory Commission is reviewing new deals the Postal Service wants to add or change for competitive mail services. If you use or work with these services, you can share your thoughts by October 20, 2026. These updates could affect pricing and options for businesses using special mail agreements soon.
Previous / Next Documents
Previous: 2025-09218, International Product Change-Priority Mail Express International, Priority Mail International & Commercial ePacket Agreement
The Postal Service is adding a new contract for Priority Mail Express International, Priority Mail International, and Commercial ePacket to its competitive product list. This change affects businesses and customers using these international shipping services and aims to improve options and pricing. The update was filed on May 15, 2025, and officially announced on May 22, 2025.
Next: 2025-09224, Khursheed Haider, M.D.; Decision and Order
Dr. Khursheed Haider from California lost his DEA registration because his medical license expired and he can no longer legally handle controlled substances. He didn’t ask for a hearing, so the DEA officially revoked his registration starting May 22, 2025. This means Dr. Haider can’t prescribe or manage controlled drugs anymore, affecting his medical practice and patients.